跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES
Approved
STANDARD
OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES
Takeda France S.A.S.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 23, 2021
Approval ID
7f4b2e847c58a604
Company
Takeda France S.A.S.
Type
Standard
Approval Details
Approval Id
7f4b2e847c58a604
Drug Cima Aemps Name
OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES
Register Number
340039239989IP
Holder Company Name
Takeda France S.A.S.
Marketing Company Name
Melyfarma S.L.
Authorization Date
2021-12-23
Dosage Form
COMPRIMIDO BUCODISPERSABLE
Dose
30 mg lansoprazol
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Takeda France S.A.S.
Active Ingredients
LANSOPRAZOL
30,0 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 23, 2021
Approval ID
7f4b2e847c58a604
Type
Standard
Back to CIMA-AEMPS Approvals
